META-ANALYSIS OF RACIAL DISPARITIES IN THE CARDIOVASCULAR EFFICACY OF SODIUM GLUCOSE COTRANSPORTERS-2 INHIBITORS

被引：0
|
作者：
Jafri, S. Hammad [1 ]
Peters, Matthew [1 ]
Bhandari, Sagar [1 ]
Sagheer, Usman [1 ]
Umer, Muhammad [1 ]
Kalra, Dinesh [1 ]
机构：
[1] Univ Louisville, Louisville, KY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1284-126
引用
收藏
页码：488 / 488
页数：1
相关论文
共 50 条
  • [21] Effects of sodium-glucose cotransporter 1 and 2 inhibitors on cardiovascular and kidney outcomes in type 2 diabetes: A meta-analysis update
    Salah, Husam M.
    Al'Aref, Subhi J.
    Khan, Muhammad Shahzeb
    Al-Hawwas, Malek
    Vallurupalli, Srikanth
    Mehta, Jawahar L.
    Mounsey, J. Paul
    Greene, Stephen J.
    McGuire, Darren K.
    Lopes, Renato D.
    Fudim, Marat
    AMERICAN HEART JOURNAL, 2021, 233 : 86 - 91
  • [22] Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: A meta-analysis of cardiovascular outcome trials
    Gilbert, Richard E.
    Thorpe, Kevin E.
    DIABETES OBESITY & METABOLISM, 2019, 21 (08): : 1996 - 2000
  • [23] Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis
    Avgerinos, Ioannis
    Karagiannis, Thomas
    Matthews, David R.
    Tsapas, Apostolos
    Bekiari, Eleni
    DIABETES OBESITY & METABOLISM, 2023, 25 (10): : 3020 - 3029
  • [24] Cardiovascular outcomes in patients treated with sodium-glucose transport protein 2 inhibitors, a network meta-analysis of randomized trials
    Tornyos, Daniel
    Meuer, Maximilian
    Lukacs, Reka
    El Abdallaoui, Oumaima El Alaoui
    Kupo, Peter
    Faludi, Reka
    Komocsi, Andras
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [25] THE IMPACT OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS ON MAJOR ADVERSE CARDIOVASCULAR EVENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Nithianandan, Harrish
    Sivasekaran, Akksayan
    Sivasekaran, Ahimsan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 628 - 628
  • [26] Sodium-glucose co-transporter-2 inhibitors with and without metformin: A meta-analysis of cardiovascular, kidney and mortality outcomes
    Neuen, Brendon L.
    Arnott, Clare
    Perkovic, Vlado
    Figtree, Gemma
    de Zeeuw, Dick
    Fulcher, Greg
    Jun, Min
    Jardine, Meg J.
    Zoungas, Sophia
    Pollock, Carol
    Mahaffey, Kenneth W.
    Neal, Bruce
    Heerspink, Hiddo J. L.
    DIABETES OBESITY & METABOLISM, 2021, 23 (02): : 382 - 390
  • [27] Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in East Asians with Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Yang, Lidan
    Zhang, Lin
    He, He
    Zhang, Mei
    An, Zhenmei
    DIABETES THERAPY, 2019, 10 (05) : 1921 - 1934
  • [28] Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials
    Monami, M.
    Nardini, C.
    Mannucci, E.
    DIABETES OBESITY & METABOLISM, 2014, 16 (05): : 457 - 466
  • [29] Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in East Asians with Type 2 Diabetes: A Systematic Review and Meta-Analysis
    Lidan Yang
    Lin Zhang
    He He
    Mei Zhang
    Zhenmei An
    Diabetes Therapy, 2019, 10 : 1921 - 1934
  • [30] Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Type 1 Diabetes: A Systematic Review and Meta-analysis
    El Masri, Dana
    Jaber, Linda
    DIABETES, 2017, 66 : LB41 - LB41
12345